IonQ, Inc.

The stock remains in a powerful long-term uptrend, trading well above its 200-day moving average of 48.27 after a sharp multi-month rerating. It is still below the 52-week high of 84.64, so the setup is constructive but not yet back at peak momentum.

Wall Street stays constructive, with a Buy consensus and a 67.25 average target versus the current share price. Recent action is mixed but still positive: Jefferies trimmed its target to 85 from 90, while Morgan Stanley nudged its target up to 48.50 from 47 and Northland initiated at Outperform.

The earnings pattern has been strong, with 5 beats in the last 8 quarters and two huge upside surprises in 2026. Next-year EPS estimates are still negative at -2.37, so shareholders should watch whether revenue growth can keep outpacing losses and support the current rerating.

Recent activity leans to net selling, but most of the table is automatic equity movement from awards, in-kind transfers, and exempt transactions. The only clear discretionary signal is sales by Robert T. Cardillo and John W. Raymond, while officer and director share movements tied to F, M, and A codes look routine.

Profitability is improving at the top line but remains uneven below it. Revenue grew 7.547% year over year, gross margin was 36.1%, and operating margin was still negative at -4.0176, even as trailing EPS reached 0.39. The balance sheet is a major strength with $2.392 billion in cash and net cash of $2.362 billion.

IonQ still trades like a premium quantum hardware name, with a 149.44 P/E and a 3.184 beta that reflect high expectations and high volatility. The market is paying for scale and optionality rather than current earnings power, while the sector remains early and competitive.